Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03883126 · ClinicalTrials.gov registry record · NA
Remote Alcohol Monitoring to Facilitate Abstinence From Alcohol: Exp 1
A NA study of Alcohol Use Disorder, sponsored by Mikhail N Koffarnus.
- Active
- Registry status
- NA
- Development phase
- 211
- Enrollment target
- 3
- Study locations
NCT03883126: Active NA study of Alcohol Use Disorder, sponsored by Mikhail N Koffarnus.
NCT03883126 is a NA study of Alcohol Use Disorder that is active but no longer recruiting, run by Mikhail N Koffarnus. The registered enrollment target is 211 participants, below the 327-participant average among 184 other Alcohol Use Disorder trials with a reported enrollment target (35% lower). The trial reports 3 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03883126, a NA study of Alcohol Use Disorder, is active but no longer recruiting, sponsored by Mikhail N Koffarnus.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 211 participants
- Enrollment target
- 3
- Study locations
Study Summary
Directly reinforcing abstinence from alcohol with monetary incentives is an effective treatment for alcohol dependence, but barriers in obtaining frequent, verified biochemical measures of abstinence limit the dissemination of this treatment approach. The goal of this study is to use technological advancements to remotely, accurately, and securely monitor alcohol use with a newly developed smartphone app and breathalyzer. This treatment approach has the potential to facilitate the dissemination of an effective, evidence-based treatment for alcohol dependence to a broader population whose treatment needs are not currently being adequately met.
Primary Outcome
Breathalyzer assessments will be collected during the treatment period. This outcome measure will consist of the percentage of days without alcohol use as detected by the breathalyzers.
Conditions Studied
Interventions
- BEHAVIORAL Contingency management
Study Locations (3)
Kentucky
- Nationwide Online Enrollment from the Unversity of Kentucky - Lexington
- University of Kentucky Turfland: In-person enrollment - Lexington
Virginia
- Carilion Clinic: In person-enrollment - Roanoke
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 211 participants |
| Start Date | 2020-06-16 |
| Est. Completion | 2026-08-31 |
| Phase | NA |
What the registry record for NCT03883126 still lists
NCT03883126 is an interventional study that assigns participants to a tested intervention. The registered 211 participants enrollment target is mid-sized for trials with a published cap, below the 327-participant average among 184 other Alcohol Use Disorder trials with a reported enrollment target (35% lower).
The record links to 1 condition, with Alcohol Use Disorder appearing as the primary indexed condition, and to 1 intervention - of which Contingency management is the first listed.
NCT03883126 reports a single indexed study location in Kentucky, Virginia.
Frequently Asked Questions
What is clinical trial NCT03883126 about?
NCT03883126 is a clinical study titled "Remote Alcohol Monitoring to Facilitate Abstinence From Alcohol: Exp 1". Directly reinforcing abstinence from alcohol with monetary incentives is an effective treatment for alcohol dependence, but barriers in obtaining frequent, verified biochemical measures of abstinence limit the dissemination of this treatment approach. The goal of this study is to use technological a...
What is the current status of trial NCT03883126?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 211 participants. The study started on 2020-06-16. Estimated completion is 2026-08-31.
What conditions does trial NCT03883126 study?
This clinical trial studies the following conditions: Alcohol Use Disorder.
What interventions are being tested in trial NCT03883126?
The interventions under investigation include: Contingency management (BEHAVIORAL).
Who is sponsoring clinical trial NCT03883126?
This trial is sponsored by Mikhail N Koffarnus, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03883126 being conducted?
This trial has 3 study locations across Kentucky, Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Alcohol Use Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03883126's enrollment target sits among peer trials
211 41st of 184 higher than 144 of 184 other Alcohol Use Disorder trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Alcohol Use Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Ultrasound Neuromodulation of the Brain for Alcohol Use Disorder
RECRUITING · NA
-
TRAC-ER Intervention to Reduce Risky Alcohol Use and HIV Risk
RECRUITING · NA
-
Integrated Treatment for Enhancing Growth in Recovery During Adolescence
RECRUITING · NA
-
AAT for Alcohol Use Disorder in Veterans
RECRUITING · NA
-
Testing a PTSD m-Health Intervention to Improve Alcohol Treatment Outcomes
RECRUITING · NA
-
Validating an Autonomous Interactive Internet-Based Delivery of an Empirically Supported Cognitive Behavioral Therapy for Comorbidity
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06698796 · 211 participants · Phase 3
A Study to Understand How the Study Medicine Dazukibart Works in People With Idiopathic Inflammatory Myopathies
- NCT04228978 · 212 participants · NA
Promote Weight Loss in Obese Peripheral Artery Disease (PAD) Patients to Prevent Mobility Loss
- NCT04725721 · 212 participants · NA
Testing FIRST in Youth Outpatient Psychotherapy
- NCT06257576 · 212 participants · Phase 3
Function of Tamsulosin in Older Males Undergoing Surgery with Indwelling Catheter
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI